Role of Oral and Gut Microbiota in Childhood Obesity
Overview
Authors
Affiliations
Childhood obesity not only causes damage to children's respiratory, cardiovascular, endocrine, motor, and other systems but also is a significant risk factor for metabolic diseases such as obesity in adulthood, which has become one of the serious public health problems worldwide. The etiology and pathogenesis of obesity are complex. In addition to genetic and lifestyle factors, recent studies have found that the microbes in the digestive tract play a crucial role in the occurrence and development of obesity. Among them, the gut microbiota has been confirmed to be one of the important pathogenic factors of obesity, which can mediate the occurrence and development of obesity by interfering with the balance of host energy metabolism and inducing low-grade chronic inflammation throughout the host. Targeting the gut microbiota to treat obesity through various methods such as fecal microbiota transplantation, dietary intervention, and probiotic supplementation has become a research hotspot in obesity treatment. In addition, the oral microbiota is also considered closely related to the occurrence and development of obesity due to its regulatory effect on the balance of gut microbiota. Exploring the relationship between oral and gut microbiota and childhood obesity elucidates the pathogenesis and treatment concepts of childhood obesity from a new perspective. It may provide new methods for the prevention and treatment of childhood obesity in the future.
Lei S, Khan I, Zhang X, Chen T, Xie X, Zheng X BMC Oral Health. 2024; 24(1):993.
PMID: 39182077 PMC: 11344349. DOI: 10.1186/s12903-024-04603-0.
Is oxidative stress - antioxidants imbalance the physiopathogenic core in pediatric obesity?.
Lupu A, Fotea S, Jechel E, Starcea I, Ioniuc I, Knieling A Front Immunol. 2024; 15:1394869.
PMID: 39176098 PMC: 11338799. DOI: 10.3389/fimmu.2024.1394869.
Genetics, pharmacotherapy, and dietary interventions in childhood obesity.
Son J J Pharm Pharm Sci. 2024; 27:12861.
PMID: 38863827 PMC: 11165095. DOI: 10.3389/jpps.2024.12861.
Williams A, Porter J, Kingsley K, Howard K Pathogens. 2024; 13(4).
PMID: 38668293 PMC: 11053746. DOI: 10.3390/pathogens13040338.
Kleniewska P, Pawliczak R Pharmacol Rep. 2023; 75(5):1166-1176.
PMID: 37730940 PMC: 10539412. DOI: 10.1007/s43440-023-00527-8.